The diagnosis of mild cognitive impairment due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's…
- M. Albert, S. DeKosky, C. Phelps
- Psychology, MedicineAlzheimer's & Dementia
- 1 May 2011
Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS–ADRDA criteria
- B. Dubois, H. Feldman, P. Scheltens
- BiologyLancet Neurology
- 1 August 2007
Validation of the NPI-Q, a brief clinical form of the Neuropsychiatric Inventory.
- D. Kaufer, J. Cummings, S. DeKosky
- Psychology, MedicineThe Journal of Neuropsychiatry and Clinical…
- 1 May 2000
A brief questionnaire form of the NPI (NPI-Q), intended for use in routine clinical practice, is developed and cross-validated in 60 Alzheimer's patients, providing a brief, reliable, informant-based assessment of neuropsychiatric symptoms and associated caregiver distress.
Practice parameter: Early detection of dementia: Mild cognitive impairment (an evidence-based review)
- R. Petersen, J. Stevens, M. Ganguli, E. Tangalos, J. Cummings, S. DeKosky
- Psychology, MedicineNeurology
- 8 May 2001
Screening different groups of elderly individuals in a general or specialty practice would be beneficial in detecting dementia and persons with memory impairment who were not demented were characterized in the literature as having mild cognitive impairment.
Prevalence of neuropsychiatric symptoms in dementia and mild cognitive impairment: results from the cardiovascular health study.
- C. Lyketsos, O. Lopez, B. Jones, A. Fitzpatrick, J. Breitner, S. DeKosky
- Psychology, MedicineJAMA
- 25 September 2002
These are the first population-based estimates for neuropsychiatric symptoms in MCI, indicating a high prevalence associated with this condition as well.
Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria
- B. Dubois, H. Feldman, J. Cummings
- MedicineLancet Neurology
- 1 June 2014
Revising the definition of Alzheimer's disease: a new lexicon
- B. Dubois, H. Feldman, P. Scheltens
- MedicineLancet Neurology
- 1 November 2010
Common variants in MS4A4/MS4A6E, CD2uAP, CD33, and EPHA1 are associated with late-onset Alzheimer’s disease
- A. Naj, G. Jun, G. Schellenberg
- BiologyNature Genetics
- 3 April 2011
The Alzheimer Disease Genetics Consortium (ADGC) performed a genome-wide association study of late-onset Alzheimer disease using a three-stage design consisting of a discovery stage (stage 1) and two…
Practice parameter: Diagnosis of dementia (an evidence-based review)
- D. Knopman, S. DeKosky, J. Stevens
- Medicine, PsychologyNeurology
- 8 May 2001
D diagnostic criteria for dementia have improved since the 1994 practice parameter, and further research is needed to improve clinical definitions of dementia and its subtypes, as well as to determine the utility of various instruments of neuroimaging, biomarkers, and genetic testing in increasing diagnostic accuracy.
The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging and Alzheimer's Association workgroup
- M. Albert, S. DeKosky, C. Phelps
- Psychology, Biology
- 2011
Criteria for the symptomatic predementia phase of Alzheimer’s disease (AD), referred to in this article as mild cognitive impairment due to AD, has four levels of certainty, depending on the presence and nature of the biomarker findings.
...
...